Shizuka Yamada

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cotyledonoid Dissecting Leiomyoma: A Rare Case With Rapid Regrowth After Fertility-Sparing Surgery and Hormonal Therapy.

Cotyledonoid Dissecting Leiomyoma: A Rare Case With Rapid Regrowth After Fertility-Sparing Surgery and Hormonal Therapy.

Journal: Cureus

Published: November 23, 2025

Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report.

Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report.

Journal: The journal of obstetrics and gynaecology research

Published: June 19, 2024

Attitudes toward cancer screening in regional Japan during the COVID-19 pandemic: An anonymous survey.

Attitudes toward cancer screening in regional Japan during the COVID-19 pandemic: An anonymous survey.

Journal: Cancer science

Published: May 19, 2023

Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer.

Copper content in ascitic fluid is associated with angiogenesis and progression in ovarian cancer.

Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

Published: March 10, 2021

Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: January 16, 2021

Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer.

Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer.

Journal: EJNMMI research

Published: July 20, 2020

Prognostic Value of 16α-18F-Fluoro-17β-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study.

Prognostic Value of 16α-18F-Fluoro-17β-Estradiol PET as a Predictor of Disease Outcome in Endometrial Cancer: A Prospective Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 02, 2020

Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer.

Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: February 10, 2020

Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma.

Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma.

Journal: Endocrine journal

Published: September 20, 2019

Predictive Value of 16α-[18F]-Fluoro-17β-Estradiol PET as a Biomarker of Progestin Therapy Resistance in Patients With Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer.

Predictive Value of 16α-[18F]-Fluoro-17β-Estradiol PET as a Biomarker of Progestin Therapy Resistance in Patients With Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer.

Journal: Clinical nuclear medicine

Published: May 21, 2019

Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature.

Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature.

Journal: Journal of ovarian research

Published: April 20, 2019

Selected PET radiomic features remain the same.

Selected PET radiomic features remain the same.

Journal: Oncotarget

Published: November 27, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026